Cargando…

Rationale of receptor-based antivirals against SARS

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149114/ http://dx.doi.org/10.2165/00128413-200313950-00004

Ejemplares similares

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
por: Takashita, Emi, et al.
Publicado: (2022)

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
por: Uraki, Ryuta, et al.
Publicado: (2023)

Potential for receptor-based antiviral drugs against SARS
por: Williams, Richard K, et al.
Publicado: (2003)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant
por: Takashita, Emi, et al.
Publicado: (2022)

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
por: Takashita, Emi, et al.
Publicado: (2022)

Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Antiviral pills: A potential game-changing therapy against COVID-19
por: Dhawan, Manish, et al.
Publicado: (2022)

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
por: Takashita, Emi, et al.
Publicado: (2022)

Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
por: Uraki, Ryuta, et al.
Publicado: (2023)

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
por: Imai, Masaki, et al.
Publicado: (2022)

The Rationale of Malaria Treatment in Syphilis of the Central Nervous System
por: Brooks, A. G.
Publicado: (1928)

Rationale for a new registry on EVAR: The EXTREME study
por: Sirignano, Pasqualino, et al.
Publicado: (2017)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection
por: Sauerhering, Lucie, et al.
Publicado: (2022)

Antiviral effects of oleandrin
por: Newman, R., et al.
Publicado: (2021)

WHO Living Guidelines on antivirals for COVID-19 are evidence-based
por: Owen, Andrew, et al.
Publicado: (2023)

Revalidation and rationale for high pKa values of unconjugated bilirubin
por: Ostrow, J Donald, et al.
Publicado: (2007)

Rationale of anticoagulation among patients of COVID-19 undergoing cardiac surgery
por: Sharma, Dhruva
Publicado: (2020)

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
por: Takashita, Emi, et al.
Publicado: (2022)

The expert network and electronic portal for children with respiratory and allergic symptoms: rationale and design
por: Zomer-Kooijker, Kim, et al.
Publicado: (2013)

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
por: Hills, Susan, et al.
Publicado: (2009)

Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
por: Sisa, Ivan, et al.
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Cultivation conditions and the diffusion of oxygen into culture media: The rationale for the flask-to-medium ratio in microbiology
por: Somerville, Greg A, et al.
Publicado: (2013)

The Rationale of Malaria Therapy in Late Localized Syphilis with Particular Reference to General Paralysis of the Insane
por: Brooks, A. G.
Publicado: (1947)

Early triple antiviral therapy for COVID-19
por: Lee, Nelson, et al.
Publicado: (2020)

Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021)

Reissuing the sigma receptors for SARS-CoV-2
por: Yesilkaya, Umit Haluk, et al.
Publicado: (2020)

Chloroquine drops against SARS-CoV-2 infection
por: Kumar, Jogender, et al.
Publicado: (2022)

Enoxaparin’s potential mechanisms against SARS-CoV-2
por: Afsharirad, Bentelhoda, et al.
Publicado: (2023)

Modelling the evolution of drug resistance in the presence of antiviral drugs
por: Wu, Jianhong, et al.
Publicado: (2007)

Metabolomics to Predict Antiviral Drug Efficacy in COVID-19
por: Migaud, Marie, et al.
Publicado: (2020)

Functional exhaustion of antiviral lymphocytes in COVID-19 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Host-targeting oral antiviral drugs to prevent pandemics
por: Dwek, Raymond A, et al.
Publicado: (2022)

Combining immunomodulators and antivirals for COVID-19 – Authors' reply
por: Almansa, Raquel, et al.
Publicado: (2021)

Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19
por: Demarest, James F., et al.
Publicado: (2022)

Fighting the Battle against SARS-CoV-2 as Gastroenterologists in Italy
por: Pagnini, Cristiano, et al.
Publicado: (2020)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland
por: Tibble, Holly, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eerbgtmnpk872fm3tbadugm29o